07:42 AM EDT, 10/30/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) reported Q3 non-GAAP earnings Wednesday of $1.81 per diluted share, up from $1.54 a year earlier.
Analysts polled by Capital IQ expected $1.82.
Revenue for the quarter ended Sept. 30 was $622.1 million,up from $498.8 million a year earlier.
Analysts surveyed by Capital IQ expected $602.8 million.